Oxbow Advisors’s GENEREX BIOTECHNOLOGY CORP GNBT Stock Holding History

Oxbow Advisors’s Portfolio GNBT Stock Details GNBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-10,400	Closed	–	–	241
2013 Q3	$0	Hold	10,400	–	–	﹤0.01%	223
2013 Q2	$0	Buy	+10,400	New	–	﹤0.01%	201

Other funds holding GNBT

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Oxbow Advisors's GNBT Position: Q4 2013 in Review

Oxbow Advisors sold out of GENEREX BIOTECHNOLOGY CORP (GNBT) in Q4 2013, closing a stake of 10,400 shares.

Oxbow Advisors first reported a position in GNBT in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q3 2013. 3 funds tracked by Wall St. Rank hold GNBT as of Q4 2013.

Oxbow Advisors reported no remaining GENEREX BIOTECHNOLOGY CORP position as of Q4 2013 after selling out during the quarter.
Oxbow Advisors sold 10,400 GENEREX BIOTECHNOLOGY CORP shares in Q4 2013.
Oxbow Advisors first reported a position in GENEREX BIOTECHNOLOGY CORP in Q2 2013 and held it in 2 quarters.
Oxbow Advisors's GENEREX BIOTECHNOLOGY CORP position peaked at $0 in Q3 2013.
3 funds tracked by Wall St. Rank held GENEREX BIOTECHNOLOGY CORP as of Q4 2013.

Based on Oxbow Advisors's 13F filing for Q4 2013, filed 21 Jan 2014.